A message from Dr. Kunkel
Earlier today, Rebecca Cunningham, U-M Vice President for Research, made two important announcements that are effective tomorrow, February 16:
- the density of personnel in our laboratories and research spaces can increase from 60% to 75% as long as social distancing can be maintained.
- the subset of Tier 2 human research studies (those classified as an observational study or Benefit Level 4 on the human research activation checklist) that have been paused since November may resume in-person activity. Tier 3 human research studies remain paused at this time.
Existing policies related to COVID precautions, such as mandatory masks, remain in effect. Please remember that work that can occur remotely should continue to be done in that manner.
CLICK HERE to view a spreadsheet that lists each lab with the density of personnel it can support at 75%, and below you’ll find a graphic that shows how those numbers were calculated. With this change, keep in mind that a lab’s density can only increase as much as social distancing will allow.
And finally, weekly COVID testing requirements have expanded to all U-M students – including graduate and professional students – who live on or come to campus, regardless of their vaccination status.
It has been a long 11 months, but we can see the light at the end of the tunnel. As of last Friday, Michigan Medicine had administered over 58,000 COVID vaccine doses, and case counts for the state of Michigan are dropping daily. Your efforts over the last year have been nothing short of astounding, and I invite you to VIEW THIS VIDEO for an overview of 2020 milestones and a heartfelt “thank you” for all that you’ve accomplished. You continue to have my deepest appreciation.
Steven L. Kunkel, Ph.D.
Executive Vice Dean for Research, Medical School
Chief Scientific Officer, Michigan Medicine
Peter A. Ward Distinguished University Professor
Endowed Professor of Pathology Research